ENKD1
gene geneOn this page
Also known as DKFZP434A1319FBB11
Summary
ENKD1 (enkurin domain containing 1, HGNC:25246) is a protein-coding gene on chromosome 16q22.1, encoding Enkurin domain-containing protein 1 (Q9H0I2). Microtubule-binding protein which regulates microtubule organization and stability.
Enables alpha-tubulin binding activity and microtubule binding activity. Involved in establishment of mitotic spindle orientation and non-motile cilium assembly. Located in microtubule cytoskeleton and plasma membrane.
Source: NCBI Gene 84080 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 74 total — 1 pathogenic
- MANE Select transcript:
NM_032140
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25246 |
| Approved symbol | ENKD1 |
| Name | enkurin domain containing 1 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434A1319, FBB11 |
| Ensembl gene | ENSG00000124074 |
| Ensembl biotype | protein_coding |
| OMIM | 621119 |
| Entrez | 84080 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000243878, ENST00000602409, ENST00000602415, ENST00000602531, ENST00000602642, ENST00000602644, ENST00000602942, ENST00000857832
RefSeq mRNA: 1 — MANE Select: NM_032140
NM_032140
CCDS: CCDS10844
Canonical transcript exons
ENST00000243878 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000844194 | 67666358 | 67666750 |
| ENSE00001863371 | 67662945 | 67663321 |
| ENSE00003489328 | 67666071 | 67666265 |
| ENSE00003627296 | 67663937 | 67664062 |
| ENSE00003673205 | 67663657 | 67663820 |
| ENSE00003683024 | 67663420 | 67663556 |
| ENSE00003728349 | 67664996 | 67665168 |
Expression profiles
Bgee: expression breadth ubiquitous, 228 present calls, max score 97.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7541 / max 50.0734, expressed in 1704 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157811 | 6.3827 | 1650 |
| 157812 | 0.3714 | 201 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 97.53 | gold quality |
| right uterine tube | UBERON:0001302 | 96.57 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.32 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.04 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.82 | gold quality |
| right testis | UBERON:0004534 | 94.78 | gold quality |
| left testis | UBERON:0004533 | 94.70 | gold quality |
| cerebellum | UBERON:0002037 | 93.74 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.92 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.30 | gold quality |
| lower esophagus | UBERON:0013473 | 92.27 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.11 | gold quality |
| testis | UBERON:0000473 | 92.10 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 92.06 | gold quality |
| pituitary gland | UBERON:0000007 | 91.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.80 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.63 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.58 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.24 | gold quality |
| body of uterus | UBERON:0009853 | 90.89 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.69 | gold quality |
| tibial nerve | UBERON:0001323 | 90.16 | gold quality |
| thyroid gland | UBERON:0002046 | 89.99 | gold quality |
| left ovary | UBERON:0002119 | 89.97 | gold quality |
| right ovary | UBERON:0002118 | 89.90 | gold quality |
| endocervix | UBERON:0000458 | 89.82 | gold quality |
| left uterine tube | UBERON:0001303 | 89.78 | gold quality |
| bronchus | UBERON:0002185 | 89.68 | gold quality |
| pancreas | UBERON:0001264 | 89.65 | gold quality |
| mucosa of stomach | UBERON:0001199 | 89.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting ENKD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-4252 | 98.45 | 66.37 | 987 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-326 | 98.25 | 66.44 | 1565 |
| HSA-MIR-3121-5P | 97.30 | 66.62 | 1146 |
| HSA-MIR-514A-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-514B-3P | 96.43 | 67.77 | 1048 |
Literature-anchored findings (GeneRIF, showing 2)
- Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non-small cell lung cancer cells. (PMID:33724673)
- Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development. (PMID:36960713)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | enkd1 | ENSDARG00000043550 |
| mus_musculus | Enkd1 | ENSMUSG00000013155 |
| rattus_norvegicus | Enkd1 | ENSRNOG00000024364 |
| drosophila_melanogaster | CG11125 | FBGN0033174 |
Paralogs (1): ENKUR (ENSG00000151023)
Protein
Protein identifiers
Enkurin domain-containing protein 1 — Q9H0I2 (reviewed: Q9H0I2)
All UniProt accessions (3): A0A087X0D0, Q9H0I2, R4GN60
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule-binding protein which regulates microtubule organization and stability. Promotes the stability of astral microtubules and facilitates the proper orientation of the mitotic spindle. This allows the oriented division of basal keratinocytes and contributes to epidermal stratification. Required for the assembly of both primary and motile cilia. Destabilizes the interaction between CCP110 and CEP97 by competing with CEP97 for binding to CCP110 which promotes the removal of CCP110 and CEP97 from the mother centriole and allows the initiation of ciliogenesis.
Subunit / interactions. Interacts with alpha-tubulin. Interacts (via central region) with CCP110 (via N-terminal region); competes with CEP97 for binding to CCP110.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriole. Cilium basal body. Cell projection. Cilium. Spindle. Spindle pole. Cilium axoneme.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0I2-1 | 1 | yes |
| Q9H0I2-2 | 2 |
RefSeq proteins (1): NP_115516* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027012 | Enkurin_dom | Domain |
| IPR052102 | Enkurin_domain-protein | Family |
Pfam: PF13864
UniProt features (13 total): region of interest 5, modified residue 2, splice variant 2, compositionally biased region 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0I2-F1 | 77.54 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 136, 91
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 128 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP, GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION, MYOGENIN_Q6, chr16q22, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_SPINDLE_LOCALIZATION, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_ESTABLISHMENT_OF_CELL_POLARITY, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME, GGGNNTTTCC_NFKB_Q6_01, GOBP_ORGANELLE_ASSEMBLY, GOBP_MITOTIC_CELL_CYCLE, GOBP_MOTILE_CILIUM_ASSEMBLY
GO Biological Process (4): establishment of mitotic spindle orientation (GO:0000132), motile cilium assembly (GO:0044458), non-motile cilium assembly (GO:1905515), cell projection organization (GO:0030030)
GO Molecular Function (3): microtubule binding (GO:0008017), alpha-tubulin binding (GO:0043014), protein binding (GO:0005515)
GO Cellular Component (16): spindle pole (GO:0000922), centrosome (GO:0005813), centriole (GO:0005814), cytoplasmic microtubule (GO:0005881), plasma membrane (GO:0005886), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), ciliary basal body (GO:0036064), ciliary base (GO:0097546), 9+0 non-motile cilium (GO:0097731), cytoplasm (GO:0005737), spindle (GO:0005819), cytoskeleton (GO:0005856), microtubule (GO:0005874), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| microtubule organizing center | 3 |
| intracellular membraneless organelle | 3 |
| cilium assembly | 2 |
| tubulin binding | 2 |
| microtubule | 2 |
| cytoskeleton | 2 |
| cilium | 2 |
| microtubule cytoskeleton | 2 |
| mitotic cell cycle | 1 |
| establishment of mitotic spindle localization | 1 |
| establishment of spindle orientation | 1 |
| cellular component organization | 1 |
| binding | 1 |
| spindle | 1 |
| centriole | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| ciliary plasm | 1 |
| ciliary transition zone | 1 |
| ciliary transition fiber | 1 |
| non-motile cilium | 1 |
| intracellular anatomical structure | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ENKD1 | CLHC1 | Q8NHS4 | 555 |
| ENKD1 | TMEM129 | A0AVI4 | 483 |
| ENKD1 | CALY | Q9NYX4 | 475 |
| ENKD1 | ANKRD13D | Q6ZTN6 | 446 |
| ENKD1 | GFOD2 | Q3B7J2 | 431 |
| ENKD1 | C1orf35 | Q9BU76 | 431 |
| ENKD1 | SCRN1 | Q12765 | 417 |
| ENKD1 | SLC49A3 | Q6UXD7 | 417 |
| ENKD1 | CARD6 | Q9BX69 | 374 |
| ENKD1 | DEF8 | Q6ZN54 | 373 |
| ENKD1 | DAW1 | Q8N136 | 370 |
| ENKD1 | PRM3 | Q9NNZ6 | 370 |
| ENKD1 | SERPINB11 | Q96P15 | 368 |
| ENKD1 | ANKRD13A | Q8IZ07 | 366 |
| ENKD1 | STAC3 | Q96MF2 | 359 |
IntAct
718 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PNMA2 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.870 |
| ENKD1 | PNMA2 | psi-mi:“MI:0915”(physical association) | 0.870 |
| ENKD1 | MDFI | psi-mi:“MI:0915”(physical association) | 0.830 |
| MDFI | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| TRAF2 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SPSB3 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCDC102B | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENKD1 | CDR2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENKD1 | MIPOL1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM54 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENKD1 | SPSB3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CDR2 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENKD1 | TRIM54 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ENKD1 | CCDC102B | psi-mi:“MI:0915”(physical association) | 0.720 |
| MIPOL1 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MKRN3 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ENKD1 | PHC2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ENKD1 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CEP70 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.670 |
BioGRID (254): ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), ENKD1 (Two-hybrid), SPSB3 (Two-hybrid)
ESM2 similar proteins: A6H7J2, B5G1P1, B5X7E4, E9PRG8, O70279, P53814, P58468, P86346, Q13111, Q13487, Q28IC1, Q2KIL7, Q3T078, Q58CQ0, Q5E9N0, Q5I034, Q5I0E3, Q5ZMG5, Q6CT43, Q751T1, Q758S2, Q75E67, Q7TSV9, Q7ZWE7, Q80VC9, Q80Y56, Q86WX3, Q8C3W1, Q8C6B9, Q8K305, Q8NEG2, Q8WUQ7, Q96C57, Q96DF8, Q96IY1, Q96KC8, Q99L00, Q99PT3, Q9BRJ6, Q9CS00
Diamond homologs: Q3T078, Q7TSV9, Q9H0I2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
74 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 59493 | GRCh38/hg38 16q21-22.1(chr16:64311275-68062011)x1 | Pathogenic |
SpliceAI
961 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:67663317:CTGGC:C | acceptor_gain | 1.0000 |
| 16:67663318:TGGC:T | acceptor_gain | 1.0000 |
| 16:67663320:GCC:G | acceptor_loss | 1.0000 |
| 16:67663322:C:CC | acceptor_gain | 1.0000 |
| 16:67663322:CTAC:C | acceptor_loss | 1.0000 |
| 16:67663334:C:CT | acceptor_gain | 1.0000 |
| 16:67663334:C:T | acceptor_gain | 1.0000 |
| 16:67663335:G:T | acceptor_gain | 1.0000 |
| 16:67663414:A:AC | donor_gain | 1.0000 |
| 16:67663415:C:CC | donor_gain | 1.0000 |
| 16:67663415:CTCA:C | donor_gain | 1.0000 |
| 16:67663416:TCA:T | donor_loss | 1.0000 |
| 16:67663417:CACT:C | donor_loss | 1.0000 |
| 16:67663418:A:AC | donor_gain | 1.0000 |
| 16:67663418:ACT:A | donor_gain | 1.0000 |
| 16:67663419:C:CA | donor_gain | 1.0000 |
| 16:67663419:CT:C | donor_gain | 1.0000 |
| 16:67663419:CTC:C | donor_gain | 1.0000 |
| 16:67663419:CTCT:C | donor_gain | 1.0000 |
| 16:67663419:CTCTG:C | donor_gain | 1.0000 |
| 16:67663553:CAAG:C | acceptor_gain | 1.0000 |
| 16:67663554:AAG:A | acceptor_gain | 1.0000 |
| 16:67663556:GC:G | acceptor_loss | 1.0000 |
| 16:67663557:C:CC | acceptor_gain | 1.0000 |
| 16:67663655:A:AC | donor_gain | 1.0000 |
| 16:67663656:C:CC | donor_gain | 1.0000 |
| 16:67663656:CTA:C | donor_gain | 1.0000 |
| 16:67663656:CTAA:C | donor_gain | 1.0000 |
| 16:67663656:CTAAT:C | donor_gain | 1.0000 |
| 16:67663668:ATGGC:A | donor_gain | 1.0000 |
AlphaMissense
2210 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:67663179:G:C | F341L | 0.979 |
| 16:67663179:G:T | F341L | 0.979 |
| 16:67663181:A:G | F341L | 0.979 |
| 16:67663211:C:G | A331P | 0.975 |
| 16:67663797:G:C | F201L | 0.964 |
| 16:67663797:G:T | F201L | 0.964 |
| 16:67663799:A:G | F201L | 0.964 |
| 16:67663464:A:G | M279T | 0.959 |
| 16:67663197:A:C | F335L | 0.958 |
| 16:67663197:A:T | F335L | 0.958 |
| 16:67663199:A:G | F335L | 0.958 |
| 16:67663428:A:G | L291P | 0.942 |
| 16:67663554:A:G | L249S | 0.941 |
| 16:67663309:A:G | L298P | 0.931 |
| 16:67663198:A:G | F335S | 0.925 |
| 16:67663228:A:G | L325P | 0.922 |
| 16:67663437:A:G | L288P | 0.922 |
| 16:67664024:G:C | F164L | 0.917 |
| 16:67664024:G:T | F164L | 0.917 |
| 16:67664026:A:G | F164L | 0.917 |
| 16:67663449:C:G | R284P | 0.914 |
| 16:67663545:C:G | R252P | 0.914 |
| 16:67665129:C:G | R107P | 0.914 |
| 16:67663240:A:G | L321P | 0.913 |
| 16:67663180:A:C | F341C | 0.912 |
| 16:67663297:A:G | L302P | 0.904 |
| 16:67663180:A:G | F341S | 0.900 |
| 16:67663474:G:C | H276D | 0.898 |
| 16:67663201:A:G | I334T | 0.887 |
| 16:67666408:A:G | I12T | 0.884 |
dbSNP variants (sampled 300 via entrez): RS1002497400 (16:67664480 C>T), RS1002798011 (16:67665023 C>T), RS1003259727 (16:67667385 G>A,C,T), RS1004170418 (16:67668722 G>T), RS1004685099 (16:67667518 C>T), RS1004858158 (16:67662569 C>T), RS1004991220 (16:67667160 C>T), RS1005451035 (16:67663850 C>G), RS1005797462 (16:67666913 C>A,T), RS1005846163 (16:67667176 G>C), RS1006823805 (16:67666240 C>G), RS1006918588 (16:67666575 G>A,T), RS1006956974 (16:67664159 C>T), RS1007107608 (16:67664436 C>A,G), RS1007705936 (16:67663009 C>A,T)
Disease associations
OMIM: gene MIM:621119 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002539_84 | Schizophrenia | 2.000000e-08 |
| GCST005751_4 | Empathy quotient | 9.000000e-07 |
| GCST006803_42 | Schizophrenia | 4.000000e-08 |
| GCST010002_113 | Refractive error | 2.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009183 | empathy measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| jinfukang | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.